Global Lung Cancer Vaccine Market Growth 2025-2031

February 2025 | 98 pages | ID: G8ED45A17BEDEN
LP Information

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Lung Cancer Vaccine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Lung Cancer Vaccine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Lung Cancer Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Lung Cancer Vaccine Segment by Type
  2.2.1 Subunit Vaccines
  2.2.2 Live Attenuated Vaccines
  2.2.3 Conjugate Vaccines
  2.2.4 Inactivated Vaccines
  2.2.5 Recombinant Vector Vaccines
2.3 Lung Cancer Vaccine Sales by Type
  2.3.1 Global Lung Cancer Vaccine Sales Market Share by Type (2020-2025)
  2.3.2 Global Lung Cancer Vaccine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Lung Cancer Vaccine Sale Price by Type (2020-2025)
2.4 Lung Cancer Vaccine Segment by Application
  2.4.1 Man
  2.4.2 Woman
2.5 Lung Cancer Vaccine Sales by Application
  2.5.1 Global Lung Cancer Vaccine Sale Market Share by Application (2020-2025)
  2.5.2 Global Lung Cancer Vaccine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Lung Cancer Vaccine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Lung Cancer Vaccine Breakdown Data by Company
  3.1.1 Global Lung Cancer Vaccine Annual Sales by Company (2020-2025)
  3.1.2 Global Lung Cancer Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Lung Cancer Vaccine Annual Revenue by Company (2020-2025)
  3.2.1 Global Lung Cancer Vaccine Revenue by Company (2020-2025)
  3.2.2 Global Lung Cancer Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Lung Cancer Vaccine Sale Price by Company
3.4 Key Manufacturers Lung Cancer Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Lung Cancer Vaccine Product Location Distribution
  3.4.2 Players Lung Cancer Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR LUNG CANCER VACCINE BY GEOGRAPHIC REGION

4.1 World Historic Lung Cancer Vaccine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Lung Cancer Vaccine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Lung Cancer Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lung Cancer Vaccine Market Size by Country/Region (2020-2025)
  4.2.1 Global Lung Cancer Vaccine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Lung Cancer Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lung Cancer Vaccine Sales Growth
4.4 APAC Lung Cancer Vaccine Sales Growth
4.5 Europe Lung Cancer Vaccine Sales Growth
4.6 Middle East & Africa Lung Cancer Vaccine Sales Growth

5 AMERICAS

5.1 Americas Lung Cancer Vaccine Sales by Country
  5.1.1 Americas Lung Cancer Vaccine Sales by Country (2020-2025)
  5.1.2 Americas Lung Cancer Vaccine Revenue by Country (2020-2025)
5.2 Americas Lung Cancer Vaccine Sales by Type (2020-2025)
5.3 Americas Lung Cancer Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Lung Cancer Vaccine Sales by Region
  6.1.1 APAC Lung Cancer Vaccine Sales by Region (2020-2025)
  6.1.2 APAC Lung Cancer Vaccine Revenue by Region (2020-2025)
6.2 APAC Lung Cancer Vaccine Sales by Type (2020-2025)
6.3 APAC Lung Cancer Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Lung Cancer Vaccine by Country
  7.1.1 Europe Lung Cancer Vaccine Sales by Country (2020-2025)
  7.1.2 Europe Lung Cancer Vaccine Revenue by Country (2020-2025)
7.2 Europe Lung Cancer Vaccine Sales by Type (2020-2025)
7.3 Europe Lung Cancer Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Lung Cancer Vaccine by Country
  8.1.1 Middle East & Africa Lung Cancer Vaccine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Lung Cancer Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Lung Cancer Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Lung Cancer Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lung Cancer Vaccine
10.3 Manufacturing Process Analysis of Lung Cancer Vaccine
10.4 Industry Chain Structure of Lung Cancer Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Lung Cancer Vaccine Distributors
11.3 Lung Cancer Vaccine Customer

12 WORLD FORECAST REVIEW FOR LUNG CANCER VACCINE BY GEOGRAPHIC REGION

12.1 Global Lung Cancer Vaccine Market Size Forecast by Region
  12.1.1 Global Lung Cancer Vaccine Forecast by Region (2026-2031)
  12.1.2 Global Lung Cancer Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lung Cancer Vaccine Forecast by Type (2026-2031)
12.7 Global Lung Cancer Vaccine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Information
  13.1.2 GlaxoSmithKline Lung Cancer Vaccine Product Portfolios and Specifications
  13.1.3 GlaxoSmithKline Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 GlaxoSmithKline Main Business Overview
  13.1.5 GlaxoSmithKline Latest Developments
13.2 Oncothyreon Incorporation
  13.2.1 Oncothyreon Incorporation Company Information
  13.2.2 Oncothyreon Incorporation Lung Cancer Vaccine Product Portfolios and Specifications
  13.2.3 Oncothyreon Incorporation Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Oncothyreon Incorporation Main Business Overview
  13.2.5 Oncothyreon Incorporation Latest Developments
13.3 Eli Lily
  13.3.1 Eli Lily Company Information
  13.3.2 Eli Lily Lung Cancer Vaccine Product Portfolios and Specifications
  13.3.3 Eli Lily Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Eli Lily Main Business Overview
  13.3.5 Eli Lily Latest Developments
13.4 ImClone Systems
  13.4.1 ImClone Systems Company Information
  13.4.2 ImClone Systems Lung Cancer Vaccine Product Portfolios and Specifications
  13.4.3 ImClone Systems Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 ImClone Systems Main Business Overview
  13.4.5 ImClone Systems Latest Developments
13.5 Boehringer Ingelheim
  13.5.1 Boehringer Ingelheim Company Information
  13.5.2 Boehringer Ingelheim Lung Cancer Vaccine Product Portfolios and Specifications
  13.5.3 Boehringer Ingelheim Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Boehringer Ingelheim Main Business Overview
  13.5.5 Boehringer Ingelheim Latest Developments
13.6 Merck
  13.6.1 Merck Company Information
  13.6.2 Merck Lung Cancer Vaccine Product Portfolios and Specifications
  13.6.3 Merck Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Merck Main Business Overview
  13.6.5 Merck Latest Developments
13.7 Ono Pharmaceutical
  13.7.1 Ono Pharmaceutical Company Information
  13.7.2 Ono Pharmaceutical Lung Cancer Vaccine Product Portfolios and Specifications
  13.7.3 Ono Pharmaceutical Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Ono Pharmaceutical Main Business Overview
  13.7.5 Ono Pharmaceutical Latest Developments
13.8 CureVac
  13.8.1 CureVac Company Information
  13.8.2 CureVac Lung Cancer Vaccine Product Portfolios and Specifications
  13.8.3 CureVac Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 CureVac Main Business Overview
  13.8.5 CureVac Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Lung Cancer Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Lung Cancer Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Subunit Vaccines
Table 4. Major Players of Live Attenuated Vaccines
Table 5. Major Players of Conjugate Vaccines
Table 6. Major Players of Inactivated Vaccines
Table 7. Major Players of Recombinant Vector Vaccines
Table 8. Global Lung Cancer Vaccine Sales byType (2020-2025) & (K Units)
Table 9. Global Lung Cancer Vaccine Sales Market Share byType (2020-2025)
Table 10. Global Lung Cancer Vaccine Revenue byType (2020-2025) & ($ million)
Table 11. Global Lung Cancer Vaccine Revenue Market Share byType (2020-2025)
Table 12. Global Lung Cancer Vaccine Sale Price byType (2020-2025) & (US$/Unit)
Table 13. Global Lung Cancer Vaccine Sale by Application (2020-2025) & (K Units)
Table 14. Global Lung Cancer Vaccine Sale Market Share by Application (2020-2025)
Table 15. Global Lung Cancer Vaccine Revenue by Application (2020-2025) & ($ million)
Table 16. Global Lung Cancer Vaccine Revenue Market Share by Application (2020-2025)
Table 17. Global Lung Cancer Vaccine Sale Price by Application (2020-2025) & (US$/Unit)
Table 18. Global Lung Cancer Vaccine Sales by Company (2020-2025) & (K Units)
Table 19. Global Lung Cancer Vaccine Sales Market Share by Company (2020-2025)
Table 20. Global Lung Cancer Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Lung Cancer Vaccine Revenue Market Share by Company (2020-2025)
Table 22. Global Lung Cancer Vaccine Sale Price by Company (2020-2025) & (US$/Unit)
Table 23. Key Manufacturers Lung Cancer Vaccine Producing Area Distribution and Sales Area
Table 24. Players Lung Cancer Vaccine Products Offered
Table 25. Lung Cancer Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Lung Cancer Vaccine Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Lung Cancer Vaccine Sales Market Share Geographic Region (2020-2025)
Table 30. Global Lung Cancer Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Lung Cancer Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Lung Cancer Vaccine Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Lung Cancer Vaccine Sales Market Share by Country/Region (2020-2025)
Table 34. Global Lung Cancer Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Lung Cancer Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Lung Cancer Vaccine Sales by Country (2020-2025) & (K Units)
Table 37. Americas Lung Cancer Vaccine Sales Market Share by Country (2020-2025)
Table 38. Americas Lung Cancer Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Lung Cancer Vaccine Sales byType (2020-2025) & (K Units)
Table 40. Americas Lung Cancer Vaccine Sales by Application (2020-2025) & (K Units)
Table 41. APAC Lung Cancer Vaccine Sales by Region (2020-2025) & (K Units)
Table 42. APAC Lung Cancer Vaccine Sales Market Share by Region (2020-2025)
Table 43. APAC Lung Cancer Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Lung Cancer Vaccine Sales byType (2020-2025) & (K Units)
Table 45. APAC Lung Cancer Vaccine Sales by Application (2020-2025) & (K Units)
Table 46. Europe Lung Cancer Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Europe Lung Cancer Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Lung Cancer Vaccine Sales byType (2020-2025) & (K Units)
Table 49. Europe Lung Cancer Vaccine Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Lung Cancer Vaccine Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Lung Cancer Vaccine Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Lung Cancer Vaccine Sales byType (2020-2025) & (K Units)
Table 53. Middle East & Africa Lung Cancer Vaccine Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Lung Cancer Vaccine
Table 55. Key Market Challenges & Risks of Lung Cancer Vaccine
Table 56. Key IndustryTrends of Lung Cancer Vaccine
Table 57. Lung Cancer Vaccine Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Lung Cancer Vaccine Distributors List
Table 60. Lung Cancer Vaccine Customer List
Table 61. Global Lung Cancer Vaccine SalesForecast by Region (2026-2031) & (K Units)
Table 62. Global Lung Cancer Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Lung Cancer Vaccine SalesForecast by Country (2026-2031) & (K Units)
Table 64. Americas Lung Cancer Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Lung Cancer Vaccine SalesForecast by Region (2026-2031) & (K Units)
Table 66. APAC Lung Cancer Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Lung Cancer Vaccine SalesForecast by Country (2026-2031) & (K Units)
Table 68. Europe Lung Cancer Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Lung Cancer Vaccine SalesForecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Lung Cancer Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Lung Cancer Vaccine SalesForecast byType (2026-2031) & (K Units)
Table 72. Global Lung Cancer Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Lung Cancer Vaccine SalesForecast by Application (2026-2031) & (K Units)
Table 74. Global Lung Cancer Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. GlaxoSmithKline Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 76. GlaxoSmithKline Lung Cancer Vaccine Product Portfolios and Specifications
Table 77. GlaxoSmithKline Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. GlaxoSmithKline Main Business
Table 79. GlaxoSmithKline Latest Developments
Table 80. Oncothyreon Incorporation Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Oncothyreon Incorporation Lung Cancer Vaccine Product Portfolios and Specifications
Table 82. Oncothyreon Incorporation Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Oncothyreon Incorporation Main Business
Table 84. Oncothyreon Incorporation Latest Developments
Table 85. Eli Lily Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. Eli Lily Lung Cancer Vaccine Product Portfolios and Specifications
Table 87. Eli Lily Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Eli Lily Main Business
Table 89. Eli Lily Latest Developments
Table 90. ImClone Systems Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. ImClone Systems Lung Cancer Vaccine Product Portfolios and Specifications
Table 92. ImClone Systems Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. ImClone Systems Main Business
Table 94. ImClone Systems Latest Developments
Table 95. Boehringer Ingelheim Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Boehringer Ingelheim Lung Cancer Vaccine Product Portfolios and Specifications
Table 97. Boehringer Ingelheim Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Boehringer Ingelheim Main Business
Table 99. Boehringer Ingelheim Latest Developments
Table 100. Merck Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Merck Lung Cancer Vaccine Product Portfolios and Specifications
Table 102. Merck Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Merck Main Business
Table 104. Merck Latest Developments
Table 105. Ono Pharmaceutical Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Ono Pharmaceutical Lung Cancer Vaccine Product Portfolios and Specifications
Table 107. Ono Pharmaceutical Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Ono Pharmaceutical Main Business
Table 109. Ono Pharmaceutical Latest Developments
Table 110. CureVac Basic Information, Lung Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. CureVac Lung Cancer Vaccine Product Portfolios and Specifications
Table 112. CureVac Lung Cancer Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. CureVac Main Business
Table 114. CureVac Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Lung Cancer Vaccine
Figure 2. Lung Cancer Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lung Cancer Vaccine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Lung Cancer Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Lung Cancer Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Lung Cancer Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Lung Cancer Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Subunit Vaccines
Figure 12. Product Picture of Live Attenuated Vaccines
Figure 13. Product Picture of Conjugate Vaccines
Figure 14. Product Picture of Inactivated Vaccines
Figure 15. Product Picture of Recombinant Vector Vaccines
Figure 16. Global Lung Cancer Vaccine Sales Market Share byType in 2025
Figure 17. Global Lung Cancer Vaccine Revenue Market Share byType (2020-2025)
Figure 18. Lung Cancer Vaccine Consumed in Man
Figure 19. Global Lung Cancer Vaccine Market: Man (2020-2025) & (K Units)
Figure 20. Lung Cancer Vaccine Consumed in Woman
Figure 21. Global Lung Cancer Vaccine Market: Woman (2020-2025) & (K Units)
Figure 22. Global Lung Cancer Vaccine Sale Market Share by Application (2024)
Figure 23. Global Lung Cancer Vaccine Revenue Market Share by Application in 2025
Figure 24. Lung Cancer Vaccine Sales by Company in 2025 (K Units)
Figure 25. Global Lung Cancer Vaccine Sales Market Share by Company in 2025
Figure 26. Lung Cancer Vaccine Revenue by Company in 2025 ($ millions)
Figure 27. Global Lung Cancer Vaccine Revenue Market Share by Company in 2025
Figure 28. Global Lung Cancer Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Lung Cancer Vaccine Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Lung Cancer Vaccine Sales 2020-2025 (K Units)
Figure 31. Americas Lung Cancer Vaccine Revenue 2020-2025 ($ millions)
Figure 32. APAC Lung Cancer Vaccine Sales 2020-2025 (K Units)
Figure 33. APAC Lung Cancer Vaccine Revenue 2020-2025 ($ millions)
Figure 34. Europe Lung Cancer Vaccine Sales 2020-2025 (K Units)
Figure 35. Europe Lung Cancer Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Lung Cancer Vaccine Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Lung Cancer Vaccine Revenue 2020-2025 ($ millions)
Figure 38. Americas Lung Cancer Vaccine Sales Market Share by Country in 2025
Figure 39. Americas Lung Cancer Vaccine Revenue Market Share by Country (2020-2025)
Figure 40. Americas Lung Cancer Vaccine Sales Market Share byType (2020-2025)
Figure 41. Americas Lung Cancer Vaccine Sales Market Share by Application (2020-2025)
Figure 42. United States Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Lung Cancer Vaccine Sales Market Share by Region in 2025
Figure 47. APAC Lung Cancer Vaccine Revenue Market Share by Region (2020-2025)
Figure 48. APAC Lung Cancer Vaccine Sales Market Share byType (2020-2025)
Figure 49. APAC Lung Cancer Vaccine Sales Market Share by Application (2020-2025)
Figure 50. China Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. India Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Lung Cancer Vaccine Sales Market Share by Country in 2025
Figure 58. Europe Lung Cancer Vaccine Revenue Market Share by Country (2020-2025)
Figure 59. Europe Lung Cancer Vaccine Sales Market Share byType (2020-2025)
Figure 60. Europe Lung Cancer Vaccine Sales Market Share by Application (2020-2025)
Figure 61. Germany Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62.France Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Lung Cancer Vaccine Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Lung Cancer Vaccine Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Lung Cancer Vaccine Sales Market Share by Application (2020-2025)
Figure 69. Egypt Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Lung Cancer Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Lung Cancer Vaccine in 2025
Figure 75. Manufacturing Process Analysis of Lung Cancer Vaccine
Figure 76. Industry Chain Structure of Lung Cancer Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Lung Cancer Vaccine Sales MarketForecast by Region (2026-2031)
Figure 79. Global Lung Cancer Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Lung Cancer Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Lung Cancer Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Lung Cancer Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Lung Cancer Vaccine Revenue Market ShareForecast by Application (2026-2031)